Global Durvalumab Market Research Report 2025(Status and Outlook)
This report offers a comprehensive and in-depth analysis of the global Durvalumab market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Durvalumab market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Durvalumab market.
Global Durvalumab Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Medimmune (AstraZeneca)
Market Segmentation (by Type)
2.4mL Injection
10mL Injection
Market Segmentation (by Application)
Locally Advanced Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Durvalumab Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Durvalumab, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Durvalumab market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Durvalumab market.
Global Durvalumab Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Medimmune (AstraZeneca)
Market Segmentation (by Type)
2.4mL Injection
10mL Injection
Market Segmentation (by Application)
Locally Advanced Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Durvalumab Market
- Overview of the regional outlook of the Durvalumab Market:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Durvalumab Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Durvalumab, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Durvalumab
1.2 Key Market Segments
1.2.1 Durvalumab Segment by Type
1.2.2 Durvalumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DURVALUMAB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Durvalumab Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Durvalumab Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DURVALUMAB MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Durvalumab Product Life Cycle
3.3 Global Durvalumab Sales by Manufacturers (2020-2025)
3.4 Global Durvalumab Revenue Market Share by Manufacturers (2020-2025)
3.5 Durvalumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Durvalumab Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Durvalumab Market Competitive Situation and Trends
3.8.1 Durvalumab Market Concentration Rate
3.8.2 Global 5 and 10 Largest Durvalumab Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DURVALUMAB INDUSTRY CHAIN ANALYSIS
4.1 Durvalumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DURVALUMAB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Durvalumab Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Durvalumab Market
5.7 ESG Ratings of Leading Companies
6 DURVALUMAB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Durvalumab Sales Market Share by Type (2020-2025)
6.3 Global Durvalumab Market Size Market Share by Type (2020-2025)
6.4 Global Durvalumab Price by Type (2020-2025)
7 DURVALUMAB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Durvalumab Market Sales by Application (2020-2025)
7.3 Global Durvalumab Market Size (M USD) by Application (2020-2025)
7.4 Global Durvalumab Sales Growth Rate by Application (2020-2025)
8 DURVALUMAB MARKET SALES BY REGION
8.1 Global Durvalumab Sales by Region
8.1.1 Global Durvalumab Sales by Region
8.1.2 Global Durvalumab Sales Market Share by Region
8.2 Global Durvalumab Market Size by Region
8.2.1 Global Durvalumab Market Size by Region
8.2.2 Global Durvalumab Market Size Market Share by Region
8.3 North America
8.3.1 North America Durvalumab Sales by Country
8.3.2 North America Durvalumab Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Durvalumab Sales by Country
8.4.2 Europe Durvalumab Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Durvalumab Sales by Region
8.5.2 Asia Pacific Durvalumab Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Durvalumab Sales by Country
8.6.2 South America Durvalumab Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Durvalumab Sales by Region
8.7.2 Middle East and Africa Durvalumab Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DURVALUMAB MARKET PRODUCTION BY REGION
9.1 Global Production of Durvalumab by Region(2020-2025)
9.2 Global Durvalumab Revenue Market Share by Region (2020-2025)
9.3 Global Durvalumab Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Durvalumab Production
9.4.1 North America Durvalumab Production Growth Rate (2020-2025)
9.4.2 North America Durvalumab Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Durvalumab Production
9.5.1 Europe Durvalumab Production Growth Rate (2020-2025)
9.5.2 Europe Durvalumab Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Durvalumab Production (2020-2025)
9.6.1 Japan Durvalumab Production Growth Rate (2020-2025)
9.6.2 Japan Durvalumab Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Durvalumab Production (2020-2025)
9.7.1 China Durvalumab Production Growth Rate (2020-2025)
9.7.2 China Durvalumab Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Medimmune (AstraZeneca)
10.1.1 Medimmune (AstraZeneca) Basic Information
10.1.2 Medimmune (AstraZeneca) Durvalumab Product Overview
10.1.3 Medimmune (AstraZeneca) Durvalumab Product Market Performance
10.1.4 Medimmune (AstraZeneca) Business Overview
10.1.5 Medimmune (AstraZeneca) SWOT Analysis
10.1.6 Medimmune (AstraZeneca) Recent Developments
11 DURVALUMAB MARKET FORECAST BY REGION
11.1 Global Durvalumab Market Size Forecast
11.2 Global Durvalumab Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Durvalumab Market Size Forecast by Country
11.2.3 Asia Pacific Durvalumab Market Size Forecast by Region
11.2.4 South America Durvalumab Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Durvalumab by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Durvalumab Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Durvalumab by Type (2026-2033)
12.1.2 Global Durvalumab Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Durvalumab by Type (2026-2033)
12.2 Global Durvalumab Market Forecast by Application (2026-2033)
12.2.1 Global Durvalumab Sales (K MT) Forecast by Application
12.2.2 Global Durvalumab Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Durvalumab
1.2 Key Market Segments
1.2.1 Durvalumab Segment by Type
1.2.2 Durvalumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DURVALUMAB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Durvalumab Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Durvalumab Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DURVALUMAB MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Durvalumab Product Life Cycle
3.3 Global Durvalumab Sales by Manufacturers (2020-2025)
3.4 Global Durvalumab Revenue Market Share by Manufacturers (2020-2025)
3.5 Durvalumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Durvalumab Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Durvalumab Market Competitive Situation and Trends
3.8.1 Durvalumab Market Concentration Rate
3.8.2 Global 5 and 10 Largest Durvalumab Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DURVALUMAB INDUSTRY CHAIN ANALYSIS
4.1 Durvalumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DURVALUMAB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Durvalumab Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Durvalumab Market
5.7 ESG Ratings of Leading Companies
6 DURVALUMAB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Durvalumab Sales Market Share by Type (2020-2025)
6.3 Global Durvalumab Market Size Market Share by Type (2020-2025)
6.4 Global Durvalumab Price by Type (2020-2025)
7 DURVALUMAB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Durvalumab Market Sales by Application (2020-2025)
7.3 Global Durvalumab Market Size (M USD) by Application (2020-2025)
7.4 Global Durvalumab Sales Growth Rate by Application (2020-2025)
8 DURVALUMAB MARKET SALES BY REGION
8.1 Global Durvalumab Sales by Region
8.1.1 Global Durvalumab Sales by Region
8.1.2 Global Durvalumab Sales Market Share by Region
8.2 Global Durvalumab Market Size by Region
8.2.1 Global Durvalumab Market Size by Region
8.2.2 Global Durvalumab Market Size Market Share by Region
8.3 North America
8.3.1 North America Durvalumab Sales by Country
8.3.2 North America Durvalumab Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Durvalumab Sales by Country
8.4.2 Europe Durvalumab Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Durvalumab Sales by Region
8.5.2 Asia Pacific Durvalumab Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Durvalumab Sales by Country
8.6.2 South America Durvalumab Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Durvalumab Sales by Region
8.7.2 Middle East and Africa Durvalumab Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DURVALUMAB MARKET PRODUCTION BY REGION
9.1 Global Production of Durvalumab by Region(2020-2025)
9.2 Global Durvalumab Revenue Market Share by Region (2020-2025)
9.3 Global Durvalumab Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Durvalumab Production
9.4.1 North America Durvalumab Production Growth Rate (2020-2025)
9.4.2 North America Durvalumab Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Durvalumab Production
9.5.1 Europe Durvalumab Production Growth Rate (2020-2025)
9.5.2 Europe Durvalumab Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Durvalumab Production (2020-2025)
9.6.1 Japan Durvalumab Production Growth Rate (2020-2025)
9.6.2 Japan Durvalumab Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Durvalumab Production (2020-2025)
9.7.1 China Durvalumab Production Growth Rate (2020-2025)
9.7.2 China Durvalumab Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Medimmune (AstraZeneca)
10.1.1 Medimmune (AstraZeneca) Basic Information
10.1.2 Medimmune (AstraZeneca) Durvalumab Product Overview
10.1.3 Medimmune (AstraZeneca) Durvalumab Product Market Performance
10.1.4 Medimmune (AstraZeneca) Business Overview
10.1.5 Medimmune (AstraZeneca) SWOT Analysis
10.1.6 Medimmune (AstraZeneca) Recent Developments
11 DURVALUMAB MARKET FORECAST BY REGION
11.1 Global Durvalumab Market Size Forecast
11.2 Global Durvalumab Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Durvalumab Market Size Forecast by Country
11.2.3 Asia Pacific Durvalumab Market Size Forecast by Region
11.2.4 South America Durvalumab Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Durvalumab by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Durvalumab Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Durvalumab by Type (2026-2033)
12.1.2 Global Durvalumab Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Durvalumab by Type (2026-2033)
12.2 Global Durvalumab Market Forecast by Application (2026-2033)
12.2.1 Global Durvalumab Sales (K MT) Forecast by Application
12.2.2 Global Durvalumab Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Durvalumab Market Size Comparison by Region (M USD)
Table 5. Global Durvalumab Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Durvalumab Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Durvalumab Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Durvalumab Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Durvalumab as of 2024)
Table 10. Global Market Durvalumab Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Durvalumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Durvalumab Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Durvalumab Sales by Type (K MT)
Table 26. Global Durvalumab Market Size by Type (M USD)
Table 27. Global Durvalumab Sales (K MT) by Type (2020-2025)
Table 28. Global Durvalumab Sales Market Share by Type (2020-2025)
Table 29. Global Durvalumab Market Size (M USD) by Type (2020-2025)
Table 30. Global Durvalumab Market Size Share by Type (2020-2025)
Table 31. Global Durvalumab Price (USD/KG) by Type (2020-2025)
Table 32. Global Durvalumab Sales (K MT) by Application
Table 33. Global Durvalumab Market Size by Application
Table 34. Global Durvalumab Sales by Application (2020-2025) & (K MT)
Table 35. Global Durvalumab Sales Market Share by Application (2020-2025)
Table 36. Global Durvalumab Market Size by Application (2020-2025) & (M USD)
Table 37. Global Durvalumab Market Share by Application (2020-2025)
Table 38. Global Durvalumab Sales Growth Rate by Application (2020-2025)
Table 39. Global Durvalumab Sales by Region (2020-2025) & (K MT)
Table 40. Global Durvalumab Sales Market Share by Region (2020-2025)
Table 41. Global Durvalumab Market Size by Region (2020-2025) & (M USD)
Table 42. Global Durvalumab Market Size Market Share by Region (2020-2025)
Table 43. North America Durvalumab Sales by Country (2020-2025) & (K MT)
Table 44. North America Durvalumab Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Durvalumab Sales by Country (2020-2025) & (K MT)
Table 46. Europe Durvalumab Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Durvalumab Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Durvalumab Market Size by Region (2020-2025) & (M USD)
Table 49. South America Durvalumab Sales by Country (2020-2025) & (K MT)
Table 50. South America Durvalumab Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Durvalumab Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Durvalumab Market Size by Region (2020-2025) & (M USD)
Table 53. Global Durvalumab Production (K MT) by Region(2020-2025)
Table 54. Global Durvalumab Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Durvalumab Revenue Market Share by Region (2020-2025)
Table 56. Global Durvalumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Durvalumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Durvalumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Durvalumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Durvalumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Medimmune (AstraZeneca) Basic Information
Table 62. Medimmune (AstraZeneca) Durvalumab Product Overview
Table 63. Medimmune (AstraZeneca) Durvalumab Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Medimmune (AstraZeneca) Business Overview
Table 65. Medimmune (AstraZeneca) SWOT Analysis
Table 66. Medimmune (AstraZeneca) Recent Developments
Table 67. Global Durvalumab Sales Forecast by Region (2026-2033) & (K MT)
Table 68. Global Durvalumab Market Size Forecast by Region (2026-2033) & (M USD)
Table 69. North America Durvalumab Sales Forecast by Country (2026-2033) & (K MT)
Table 70. North America Durvalumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 71. Europe Durvalumab Sales Forecast by Country (2026-2033) & (K MT)
Table 72. Europe Durvalumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 73. Asia Pacific Durvalumab Sales Forecast by Region (2026-2033) & (K MT)
Table 74. Asia Pacific Durvalumab Market Size Forecast by Region (2026-2033) & (M USD)
Table 75. South America Durvalumab Sales Forecast by Country (2026-2033) & (K MT)
Table 76. South America Durvalumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 77. Middle East and Africa Durvalumab Sales Forecast by Country (2026-2033) & (Units)
Table 78. Middle East and Africa Durvalumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 79. Global Durvalumab Sales Forecast by Type (2026-2033) & (K MT)
Table 80. Global Durvalumab Market Size Forecast by Type (2026-2033) & (M USD)
Table 81. Global Durvalumab Price Forecast by Type (2026-2033) & (USD/KG)
Table 82. Global Durvalumab Sales (K MT) Forecast by Application (2026-2033)
Table 83. Global Durvalumab Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Durvalumab Market Size Comparison by Region (M USD)
Table 5. Global Durvalumab Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Durvalumab Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Durvalumab Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Durvalumab Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Durvalumab as of 2024)
Table 10. Global Market Durvalumab Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Durvalumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Durvalumab Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Durvalumab Sales by Type (K MT)
Table 26. Global Durvalumab Market Size by Type (M USD)
Table 27. Global Durvalumab Sales (K MT) by Type (2020-2025)
Table 28. Global Durvalumab Sales Market Share by Type (2020-2025)
Table 29. Global Durvalumab Market Size (M USD) by Type (2020-2025)
Table 30. Global Durvalumab Market Size Share by Type (2020-2025)
Table 31. Global Durvalumab Price (USD/KG) by Type (2020-2025)
Table 32. Global Durvalumab Sales (K MT) by Application
Table 33. Global Durvalumab Market Size by Application
Table 34. Global Durvalumab Sales by Application (2020-2025) & (K MT)
Table 35. Global Durvalumab Sales Market Share by Application (2020-2025)
Table 36. Global Durvalumab Market Size by Application (2020-2025) & (M USD)
Table 37. Global Durvalumab Market Share by Application (2020-2025)
Table 38. Global Durvalumab Sales Growth Rate by Application (2020-2025)
Table 39. Global Durvalumab Sales by Region (2020-2025) & (K MT)
Table 40. Global Durvalumab Sales Market Share by Region (2020-2025)
Table 41. Global Durvalumab Market Size by Region (2020-2025) & (M USD)
Table 42. Global Durvalumab Market Size Market Share by Region (2020-2025)
Table 43. North America Durvalumab Sales by Country (2020-2025) & (K MT)
Table 44. North America Durvalumab Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Durvalumab Sales by Country (2020-2025) & (K MT)
Table 46. Europe Durvalumab Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Durvalumab Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Durvalumab Market Size by Region (2020-2025) & (M USD)
Table 49. South America Durvalumab Sales by Country (2020-2025) & (K MT)
Table 50. South America Durvalumab Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Durvalumab Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Durvalumab Market Size by Region (2020-2025) & (M USD)
Table 53. Global Durvalumab Production (K MT) by Region(2020-2025)
Table 54. Global Durvalumab Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Durvalumab Revenue Market Share by Region (2020-2025)
Table 56. Global Durvalumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Durvalumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Durvalumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Durvalumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Durvalumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Medimmune (AstraZeneca) Basic Information
Table 62. Medimmune (AstraZeneca) Durvalumab Product Overview
Table 63. Medimmune (AstraZeneca) Durvalumab Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Medimmune (AstraZeneca) Business Overview
Table 65. Medimmune (AstraZeneca) SWOT Analysis
Table 66. Medimmune (AstraZeneca) Recent Developments
Table 67. Global Durvalumab Sales Forecast by Region (2026-2033) & (K MT)
Table 68. Global Durvalumab Market Size Forecast by Region (2026-2033) & (M USD)
Table 69. North America Durvalumab Sales Forecast by Country (2026-2033) & (K MT)
Table 70. North America Durvalumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 71. Europe Durvalumab Sales Forecast by Country (2026-2033) & (K MT)
Table 72. Europe Durvalumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 73. Asia Pacific Durvalumab Sales Forecast by Region (2026-2033) & (K MT)
Table 74. Asia Pacific Durvalumab Market Size Forecast by Region (2026-2033) & (M USD)
Table 75. South America Durvalumab Sales Forecast by Country (2026-2033) & (K MT)
Table 76. South America Durvalumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 77. Middle East and Africa Durvalumab Sales Forecast by Country (2026-2033) & (Units)
Table 78. Middle East and Africa Durvalumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 79. Global Durvalumab Sales Forecast by Type (2026-2033) & (K MT)
Table 80. Global Durvalumab Market Size Forecast by Type (2026-2033) & (M USD)
Table 81. Global Durvalumab Price Forecast by Type (2026-2033) & (USD/KG)
Table 82. Global Durvalumab Sales (K MT) Forecast by Application (2026-2033)
Table 83. Global Durvalumab Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Durvalumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Durvalumab Market Size (M USD), 2024-2033
Figure 5. Global Durvalumab Market Size (M USD) (2020-2033)
Figure 6. Global Durvalumab Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Durvalumab Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Durvalumab Product Life Cycle
Figure 13. Durvalumab Sales Share by Manufacturers in 2024
Figure 14. Global Durvalumab Revenue Share by Manufacturers in 2024
Figure 15. Durvalumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Durvalumab Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Durvalumab Revenue in 2024
Figure 18. Industry Chain Map of Durvalumab
Figure 19. Global Durvalumab Market PEST Analysis
Figure 20. Global Durvalumab Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Durvalumab Market Share by Type
Figure 27. Sales Market Share of Durvalumab by Type (2020-2025)
Figure 28. Sales Market Share of Durvalumab by Type in 2024
Figure 29. Market Size Share of Durvalumab by Type (2020-2025)
Figure 30. Market Size Share of Durvalumab by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Durvalumab Market Share by Application
Figure 33. Global Durvalumab Sales Market Share by Application (2020-2025)
Figure 34. Global Durvalumab Sales Market Share by Application in 2024
Figure 35. Global Durvalumab Market Share by Application (2020-2025)
Figure 36. Global Durvalumab Market Share by Application in 2024
Figure 37. Global Durvalumab Sales Growth Rate by Application (2020-2025)
Figure 38. Global Durvalumab Sales Market Share by Region (2020-2025)
Figure 39. Global Durvalumab Market Size Market Share by Region (2020-2025)
Figure 40. North America Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Durvalumab Sales Market Share by Country in 2024
Figure 43. North America Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Durvalumab Market Size Market Share by Country in 2024
Figure 45. U.S. Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Durvalumab Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Durvalumab Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Durvalumab Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Durvalumab Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Durvalumab Sales Market Share by Country in 2024
Figure 53. Europe Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Durvalumab Market Size Market Share by Country in 2024
Figure 55. Germany Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Durvalumab Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Durvalumab Sales Market Share by Region in 2024
Figure 67. Asia Pacific Durvalumab Market Size Market Share by Region in 2024
Figure 68. China Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Durvalumab Sales and Growth Rate (K MT)
Figure 79. South America Durvalumab Sales Market Share by Country in 2024
Figure 80. South America Durvalumab Market Size and Growth Rate (M USD)
Figure 81. South America Durvalumab Market Size Market Share by Country in 2024
Figure 82. Brazil Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Durvalumab Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Durvalumab Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Durvalumab Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Durvalumab Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Durvalumab Production Market Share by Region (2020-2025)
Figure 103. North America Durvalumab Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Durvalumab Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Durvalumab Production (K MT) Growth Rate (2020-2025)
Figure 106. China Durvalumab Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Durvalumab Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Durvalumab Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Durvalumab Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Durvalumab Market Share Forecast by Type (2026-2033)
Figure 111. Global Durvalumab Sales Forecast by Application (2026-2033)
Figure 112. Global Durvalumab Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Durvalumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Durvalumab Market Size (M USD), 2024-2033
Figure 5. Global Durvalumab Market Size (M USD) (2020-2033)
Figure 6. Global Durvalumab Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Durvalumab Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Durvalumab Product Life Cycle
Figure 13. Durvalumab Sales Share by Manufacturers in 2024
Figure 14. Global Durvalumab Revenue Share by Manufacturers in 2024
Figure 15. Durvalumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Durvalumab Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Durvalumab Revenue in 2024
Figure 18. Industry Chain Map of Durvalumab
Figure 19. Global Durvalumab Market PEST Analysis
Figure 20. Global Durvalumab Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Durvalumab Market Share by Type
Figure 27. Sales Market Share of Durvalumab by Type (2020-2025)
Figure 28. Sales Market Share of Durvalumab by Type in 2024
Figure 29. Market Size Share of Durvalumab by Type (2020-2025)
Figure 30. Market Size Share of Durvalumab by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Durvalumab Market Share by Application
Figure 33. Global Durvalumab Sales Market Share by Application (2020-2025)
Figure 34. Global Durvalumab Sales Market Share by Application in 2024
Figure 35. Global Durvalumab Market Share by Application (2020-2025)
Figure 36. Global Durvalumab Market Share by Application in 2024
Figure 37. Global Durvalumab Sales Growth Rate by Application (2020-2025)
Figure 38. Global Durvalumab Sales Market Share by Region (2020-2025)
Figure 39. Global Durvalumab Market Size Market Share by Region (2020-2025)
Figure 40. North America Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Durvalumab Sales Market Share by Country in 2024
Figure 43. North America Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Durvalumab Market Size Market Share by Country in 2024
Figure 45. U.S. Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Durvalumab Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Durvalumab Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Durvalumab Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Durvalumab Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Durvalumab Sales Market Share by Country in 2024
Figure 53. Europe Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Durvalumab Market Size Market Share by Country in 2024
Figure 55. Germany Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Durvalumab Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Durvalumab Sales Market Share by Region in 2024
Figure 67. Asia Pacific Durvalumab Market Size Market Share by Region in 2024
Figure 68. China Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Durvalumab Sales and Growth Rate (K MT)
Figure 79. South America Durvalumab Sales Market Share by Country in 2024
Figure 80. South America Durvalumab Market Size and Growth Rate (M USD)
Figure 81. South America Durvalumab Market Size Market Share by Country in 2024
Figure 82. Brazil Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Durvalumab Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Durvalumab Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Durvalumab Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Durvalumab Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Durvalumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Durvalumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Durvalumab Production Market Share by Region (2020-2025)
Figure 103. North America Durvalumab Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Durvalumab Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Durvalumab Production (K MT) Growth Rate (2020-2025)
Figure 106. China Durvalumab Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Durvalumab Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Durvalumab Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Durvalumab Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Durvalumab Market Share Forecast by Type (2026-2033)
Figure 111. Global Durvalumab Sales Forecast by Application (2026-2033)
Figure 112. Global Durvalumab Market Share Forecast by Application (2026-2033)
